After a Good Second Quarter Gerresheimer Raises its Revenue Forecast Again

Informations

• Publié par: gerresheimer-ag
• Nombre de lectures: 21
• Langue: English

Extrait

After a Good Second Quarter Gerresheimer

Raises its Revenue Forecast Again

PR Newswire

DÜSSELDORF, Germany, July 11, 2012

DÜSSELDORF,

Germany

,

July 11, 2012

/PRNewswire/ --

Group revenues rise 10.3 percent to

EUR 314.0m

in Q2 2012

Adjusted EBITDA increases by 4.3 percent to

EUR 58.6m

Net income rises to

EUR 17.4m

and EPS to

EUR 0.51

Revenue forecast raised from 7 to 8 percent to 9 to 10 percent at constant

exchange rates

Expected investment volume rises from around

EUR 100m

to around

EUR 120m

The robust revenue growth trend continues at Gerresheimer AG, one

of the world's leading partners of the pharma and healthcare

industry. "Our revenues continued to develop very positively in the

second quarter of 2012. This growth is being achieved in the emerging

markets with standard glass and plastic pharmaceutical packaging

products and in the established markets with sophisticated products

for drug dosage and administration. Since we expect the growth trend

to continue in the second six months of the year, we increase our

revenue forecast for 2012 again and are planning substantial

investments in these growth markets," said Uwe Röhrhoff, CEO of

Gerresheimer AG.

Gerresheimer has experienced above average growth in revenues in the

second quarter of the 2012 financial year (

December 1, 2011

to

November 30,

2012

) of 10.3 percent to

EUR 314.0m

. At constant exchange rates growth in

revenues was 8.1 percent. All divisions contributed to this positive development.

South America

was one of the strongest regions. Here growth in revenues from

plastic containers for tablets, powders, eye drops, nose sprays and other liquid

drugs was exceptionally high. Our business with medical plastic systems, such

as insulin pen systems and diagnostic instruments, also delivered very solid

results. Demand for pre-fillable glass syringes has also developed positively.

Revenues from engineering and tools for our product pipeline also made a

positive impact on revenue.

Gerresheimer's adjusted EBITDA was

EUR 58.6m

in the second quarter of 2012,

which is 4.3 percent higher than the prior year figure. The adjusted EBITDA

margin was 18.7 percent in the second quarter (prior year 19.8 percent). Net

income after tax increased to

EUR 17.4m

, which is

EUR 4.1m

higher than the

prior quarter figure. Second quarter earnings per share of

EUR 0.51

were

EUR

0.13

higher than one year ago.

"Our medical plastic systems order book and project pipeline are looking very

good at the moment and we will continue to increase our production capacity in

this segment. New production facilities are already being constructed at our

plants in Pfreimd in

Germany

and in Horsovsky Tyn in the

Czech Republic

. And

we are already planning the next-but-one extension of our Czech production

facility. We will also be investing in our new pharmaceutical glass container

plant in

India

over the coming months. I'm confident that the groundwork we

are laying today will take us forward into a very positive future," commented

Uwe Röhrhoff.

Outlook

In light of the sustained positive development of our business operations and

the positive outlook, particularly in the Plastic Systems and Tubular Glass

divisions, Gerresheimer is now expecting revenue growth of 9 to 10 percent in

the 2012 financial year, assuming that the exchange rates remain constant.

This is an upward revision by two percentage points. The company's operating

margin (adjusted EBITDA margin) forecast is still 19.5 percent. A high order

volume in the Plastic Systems division led to the company's decision to increase

its 2012 investment budget from approximately

EUR 100m

to around

EUR

120m

.

Cross reference: The press release including tables is available at:

http://ots.de/AyUB2

You can read the online annual report at:

http://annualreport2011.gerresheimer.com

Gerresheimer AG

Benrather Strasse 18 - 20

40213 Düsseldorf

Germany

Jens Kürten

Director Corporate Communication & Marketing

Telephone [phone]

Fax

[phone]

E-Mail

[e-mail]

Internet http://www.gerresheimer.com